Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Racial differences in RAD51 expression are regulated by miRNA-214-5P and its inhibition synergizes with olaparib in triple-negative breast cancer

Fig. 1

RAD51 overexpression in TNBC is associated with poor prognosis. A Overall survival probability between breast cancer patients with high and low/medium RAD51 expression. B Disease-free survival probability between breast cancer patients with high and low/medium RAD51 expression. C Metastasis-free survival probability between breast cancer patients with high and low/medium RAD51 expression. D Relapse-free survival probability between breast cancer patients with high and low/medium RAD51 expression. E Expression of RAD51 in different subtypes of breast cancer. F RAD51 expression in breast cancer patients with diverse racial backgrounds

Back to article page